Drugs and medical devices authorized, July 1 to September 30, 2026
Safety Classified by Officially
From July 1 to September 30, 2026, Health Canada approved 16 new drug submissions (14 pharmaceuticals, 2 biologics) and 540 new medical devices, including 27 Class IV medical devices, which present the greatest potential risk. During this period, Health Canada also approved 30 generic drugs and 3 biosimilar drugs.
From July 1 to September 30, 2026, Health Canada approved 16 new drug submissions (14 pharmaceuticals, 2 biologics) and 540 new medical devices, including 27 Class IV medical devices, which present the greatest potential risk. During this period, Health Canada also approved 30 generic drugs and 3 biosimilar drugs.
For more information on these and other drug and medical device approvals, consult:
This is an extract. The publication continues at the source.
Source: Health Canada. Licence
Read the original at the source: https://www.canada.ca/en/health-canada/news/2026/10/drugs-and-medical-devices-authorized-july-1-to-september-30-2026.html
Officially imported this from Health Canada’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Health Canada — imported from official source
- Official source
- https://api.io.canada.ca/io-server/gc/news/en/v2?dept=departmentofhealth&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Health%20Canada ATOM
- Imported
- October 15, 2026 18:30
- Versions
- 1 recorded
- Identity
-
https://www.canada.ca/en/health-canada/news/2026/10/drugs-and-medical-devices-authorize...